Entera Bio Ltd. (ENTX)

NASDAQ: ENTX · Real-Time Price · USD

1.510

-0.070 (-4.43%)

At close: Feb 26, 2026, 4:00 PM EST

1.510

0.00 (0.00%)

After-hours: Feb 26, 2026, 4:00 PM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Pharmaceuticals	181.00K		134.00K	571.00K	365.00K	236.00K
Pharmaceuticals Growth	-		-76.53%	56.44%	54.66%	-52.80%
Total	181.00K		134.00K	571.00K	365.00K	236.00K
Total Growth	-		-76.53%	56.44%	54.66%	-52.80%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Israel	181.00K		134.00K	571.00K	365.00K	236.00K
Israel Growth	-		-76.53%	56.44%	54.66%	-52.80%
Total	181.00K		134.00K	571.00K	365.00K	236.00K
Total Growth	-		-76.53%	56.44%	54.66%	-52.80%

Source: S&P Global Market Intelligence.